Effectiveness of Induced Hypothermia on the Prognosis of Post-cardiac Arrest Patients: A Scoping Literature Review.
clinical improvement
hypothermia
post-cardiac arrest
preventive medicine
prognosis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
07
08
2023
medline:
8
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
Cardiac arrest (CA) is one of the leading causes of death worldwide. Therapeutic hypothermia (TH) is hypothesized to be a reliable practice for better prognosis in post-cardiac arrest (PCA) patients. Medical subject headings (MeSH) terminology was used to search PubMed Central, Medline, and PubMed databases for articles on the use of hypothermia in PCA patients. We selected various clinical trials, meta-analyses and review articles with complete texts in the English language. PCA syndrome occurs after a CA where the body experiences a state of global ischemia and multi-system dysfunction due to the release of reactive oxygen species (ROS) and inflammatory mediators. Hypothermia slows down enzymatic reactions, reduces free radical production, conserves energy, and prevents the accumulation of metabolic waste products. Delaying the time to initiate targeted temperature management (TTM) increases the mortality of patients, the appropriate temperature for TTM has always been debatable. TTM also has various deleterious effects on various organ systems from shivering, and arrhythmias to life-threatening infections but the risks outweigh the benefits for the patients when hypothermia is introduced in PCA care. Our study compares the different modalities to initiate hypothermia from surface cooling devices to intravascular cooling devices, and the adverse effects of each method compared to another.
Identifiants
pubmed: 37680442
doi: 10.7759/cureus.43064
pmc: PMC10481631
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e43064Informations de copyright
Copyright © 2023, Rohit et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Oxid Med Cell Longev. 2017;2017:8704352
pubmed: 28553435
J Am Heart Assoc. 2015 Sep 21;4(9):e002123
pubmed: 26391133
Int J Environ Res Public Health. 2021 Oct 10;18(20):
pubmed: 34682351
JAAPA. 2017 Dec;30(12):30-36
pubmed: 29210906
Eur J Clin Invest. 2018 Dec;48(12):e13026
pubmed: 30215851
Crit Care. 2007;11(4):R91
pubmed: 17718920
N Engl J Med. 2021 Jun 17;384(24):2283-2294
pubmed: 34133859
JAMA. 2019 May 7;321(17):1677-1685
pubmed: 31063573
Acute Crit Care. 2019 Aug;34(3):173-178
pubmed: 31723926
Circulation. 2015 Jul 21;132(3):182-93
pubmed: 26092673
Crit Care. 2014 Oct 11;18(5):546
pubmed: 25304549
Int J Environ Res Public Health. 2021 Nov 11;18(22):
pubmed: 34831572
Sci Rep. 2020 Sep 23;10(1):15545
pubmed: 32968178
Cardiol Ther. 2023 Mar;12(1):65-84
pubmed: 36527676
Circulation. 2008 Dec 2;118(23):2452-83
pubmed: 18948368
Resuscitation. 2021 Oct;167:160-172
pubmed: 34474143
Crit Care. 2016 Nov 26;20(1):381
pubmed: 27887653
J Int Med Res. 2015 Aug;43(4):471-82
pubmed: 26015505
Circulation. 2013 Jan 15;127(2):244-50
pubmed: 23319812
N Engl J Med. 2013 Dec 5;369(23):2197-206
pubmed: 24237006
Cureus. 2022 Sep 11;14(9):e29016
pubmed: 36118997
Acta Anaesthesiol Scand. 2022 May;66(5):615-624
pubmed: 35218019
Crit Care. 2015 Mar 16;19:103
pubmed: 25886948
Curr Treat Options Cardiovasc Med. 2020;22(11):39
pubmed: 33071538
Circulation. 2016 Sep 13;134(11):797-805
pubmed: 27562972
Curr Treat Options Neurol. 2012 Dec;14(6):541-8
pubmed: 23007950
J Chin Med Assoc. 2020 Sep;83(9):858-864
pubmed: 32371666
Circ Cardiovasc Interv. 2014 Oct;7(5):663-72
pubmed: 25270900
J Korean Med Sci. 2020 Apr 27;35(16):e108
pubmed: 32329257
Neurocrit Care. 2023 Feb;38(1):16-25
pubmed: 35896768
J Am Coll Emerg Physicians Open. 2020 May 30;1(4):327-332
pubmed: 33000055
Crit Care. 2020 Jan 6;24(1):6
pubmed: 31907075